Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Prostate cancer treatment ascertained from several sources: analysis of disagreement and error.

Goodman M, Steenland NK, Almon ML, Liff JS, Dilorio CK, Butler SO, Ekwueme DU, Hall IJ, Smith JL, Master VA, Roberts PL.

Ann Oncol. 2012 Jan;23(1):256-63. doi: 10.1093/annonc/mdr040. Epub 2011 Apr 6.

PMID:
21471565
2.

Comparison of self-reported initial treatment with medical records: results from the prostate cancer outcomes study.

Clegg LX, Potosky AL, Harlan LC, Hankey BF, Hoffman RM, Stanford JL, Hamilton AS.

Am J Epidemiol. 2001 Sep 15;154(6):582-7.

PMID:
11549564
4.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
5.

Breast and prostate cancer patient's reliability of treatment reporting.

Oberst K, Bradley CJ, Schenk M.

J Registry Manag. 2009 Spring;36(1):12-5.

PMID:
19670693
6.

Active surveillance failure for prostate cancer: does the delay in treatment increase the risk of urinary incontinence?

Radomski L, Gani J, Trottier G, Finelli A.

Can J Urol. 2012 Jun;19(3):6287-92.

PMID:
22704315
7.

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.

Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.

J Urol. 2007 Jun;177(6):2151-6; discussion 2156. Erratum in: J Urol. 2007 Sep;178(3 Pt 1):1125.

PMID:
17509305
8.

Alternative medicine use in patients with localized prostate carcinoma treated with curative intent.

Lippert MC, McClain R, Boyd JC, Theodorescu D.

Cancer. 1999 Dec 15;86(12):2642-8.

PMID:
10594859
9.

Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.

Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Feb;67(2):204-9. doi: 10.1016/j.eururo.2014.09.017. Epub 2014 Oct 5.

PMID:
25294696
10.

Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.

Westover K, Chen MH, Moul J, Robertson C, Polascik T, Dosoretz D, Katin M, Salenius S, D'Amico AV.

BJU Int. 2012 Oct;110(8):1116-21. doi: 10.1111/j.1464-410X.2012.11012.x. Epub 2012 Apr 30.

11.

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Nieder AM, Porter MP, Soloway MS.

J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.

PMID:
18801517
12.

Estimating preferences for treatments in patients with localized prostate cancer.

Ávila M, Becerra V, Guedea F, Suárez JF, Fernandez P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Cunillera O, Pardo Y, Cots F, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):277-87. doi: 10.1016/j.ijrobp.2014.09.044. Epub 2014 Dec 6.

PMID:
25491504
13.
14.

Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.

Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR; CaPSURE Investigators.

J Urol. 2007 Aug;178(2):529-34; discussion 534. Epub 2007 Jun 13.

PMID:
17570425
15.
16.

Comparison of Patient Report and Medical Records of Comorbidities: Results From a Population-Based Cohort of Patients With Prostate Cancer.

Ye F, Moon DH, Carpenter WR, Reeve BB, Usinger DS, Green RL, Spearman K, Sheets NC, Pearlstein KA, Lucero AR, Waddle MR, Godley PA, Chen RC.

JAMA Oncol. 2017 Aug 1;3(8):1035-1042. doi: 10.1001/jamaoncol.2016.6744.

17.

Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study.

Goldsbury DE, Smith DP, Armstrong BK, O'Connell DL.

BMC Health Serv Res. 2011 Oct 6;11:253. doi: 10.1186/1472-6963-11-253.

18.

The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.

Bacon CG, Giovannucci E, Testa M, Kawachi I.

J Urol. 2001 Nov;166(5):1804-10.

PMID:
11586228
19.

Erectile function after permanent prostate brachytherapy.

Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):893-902.

PMID:
11958881
20.

Patients' satisfaction with different modalities of prostate cancer therapy--a retrospective survey among 634 patients.

Wagner W, Bölling T, Hambruegge C, Hartlapp J, Krukemeyer MG.

Anticancer Res. 2011 Nov;31(11):3903-8.

PMID:
22110217

Supplemental Content

Support Center